Skip Nav Destination
Issues
1 March 2019
-
Cover Image
Cover Image
The cover shows how intratumoral oncolytic virus treatment induces dramatic remodeling of tumor microenvironment by facilitating the accumulation of CD8+ T cells. Left panel: pretreatment; right panel: post-treatment. For details, see the article by Chon and colleagues on page 1612 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Perspectives in Regulatory Science and Policy
Clinical Development of Novel Drug–Radiotherapy Combinations
Saif S. Ahmad; Marka R. Crittenden; Phuoc T. Tran; Paul G. Kluetz; Gideon M. Blumenthal; Helen Bulbeck; Richard D. Baird; Kaye J. Williams; Tim Illidge; Stephen M. Hahn; Theodore S. Lawrence; Patricia A. Spears; Amanda J. Walker; Ricky A. Sharma
Review
Clinical Trials: Targeted Therapy
Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
Sarah P. Blagden; Anne L. Hamilton; Linda Mileshkin; Shirley Wong; Agnieszka Michael; Marcia Hall; Jeffrey C. Goh; Alla S. Lisyanskaya; Michelle DeSilvio; Eleni Frangou; Euan A. Stronach; Prashanth Gopalakrishna; Tarek M. Meniawy; Hani Gabra
Author Choice
Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials
Olivier Mir; Nathan Touati; Michela Lia; Saskia Litière; Axel Le Cesne; Stefan Sleijfer; Jean-Yves Blay; Michael Leahy; Robin Young; Ron H.J. Mathijssen; Nielka P. Van Erp; Hans Gelderblom; Winette T. Van der Graaf; Alessandro Gronchi
Clinical Trials: Immunotherapy
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
Sanja Stevanović; Sarah R. Helman; John R. Wunderlich; Michelle M. Langhan; Stacey L. Doran; Mei Li M. Kwong; Robert P.T. Somerville; Christopher A. Klebanoff; Udai S. Kammula; Richard M. Sherry; James C. Yang; Steven A. Rosenberg; Christian S. Hinrichs
Author Choice
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
Guoliang Qiao; Xiaoli Wang; Lei Zhou; Xinna Zhou; Yuguang Song; Shuo Wang; Lei Zhao; Michael A. Morse; Amy Hobeika; Jin Song; Xin Yi; Xuefeng Xia; Jun Ren; Herbert Kim Lyerly
Precision Medicine and Imaging
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Julia Hess; Kristian Unger; Cornelius Maihoefer; Lars Schüttrumpf; Ludmila Wintergerst; Theresa Heider; Peter Weber; Sebastian Marschner; Herbert Braselmann; Daniel Samaga; Sebastian Kuger; Ulrike Pflugradt; Philipp Baumeister; Axel Walch; Christine Woischke; Thomas Kirchner; Martin Werner; Kristin Werner; Michael Baumann; Volker Budach; Stephanie E. Combs; Jürgen Debus; Anca-Ligia Grosu; Mechthild Krause; Annett Linge; Claus Rödel; Martin Stuschke; Daniel Zips; Horst Zitzelsberger; Ute Ganswindt; Michael Henke; Claus Belka
Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non–Small Cell Lung Cancer
Germán Corredor; Xiangxue Wang; Yu Zhou; Cheng Lu; Pingfu Fu; Konstantinos Syrigos; David L. Rimm; Michael Yang; Eduardo Romero; Kurt A. Schalper; Vamsidhar Velcheti; Anant Madabhushi
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Aura Muntasell; Federico Rojo; Sonia Servitja; Carlota Rubio-Perez; Mariona Cabo; David Tamborero; Marcel Costa-García; María Martínez-Garcia; Sílvia Menéndez; Ivonne Vazquez; Ana Lluch; Abel Gonzalez-Perez; Ana Rovira; Miguel López-Botet; Joan Albanell
Author Choice
Development and Validation of a Novel Signature to Predict Overall Survival in “Driver Gene–negative” Lung Adenocarcinoma (LUAD): Results of a Multicenter Study
Yongmei Cui; Wenfeng Fang; Chaofeng Li; Kejing Tang; Jian Zhang; Yiyan Lei; Weiling He; Sui Peng; Ming Kuang; Hui Zhang; Lili Chen; Di Xu; Cuilan Tang; Wenhui Zhang; Yuxin Zhu; Wenting Jiang; Neng Jiang; Yu Sun; Yangshan Chen; Han Wang; Yingrong Lai; Shuhua Li; Qiong He; Jianwen Zhou; Yang Zhang; Millicent Lin; Honglei Chen; Chenzhi Zhou; Chunlin Wang; Jianhong Wang; Xuenong Zou; Liantang Wang; Zunfu Ke
Translational Cancer Mechanisms and Therapy
Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy
Su Y. Lim; Jenny H. Lee; Tuba N. Gide; Alexander M. Menzies; Alexander Guminski; Matteo S. Carlino; Edmond J. Breen; Jean Y.H. Yang; Shila Ghazanfar; Richard F. Kefford; Richard A. Scolyer; Georgina V. Long; Helen Rizos
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
Emilio Cosimo; Anuradha Tarafdar; Michael W. Moles; Ailsa K. Holroyd; Natasha Malik; Mark A. Catherwood; Jodie Hay; Karen M. Dunn; Alan M. Macdonald; Sylvie M. Guichard; Declan O'Rourke; Michael T. Leach; Owen J. Sansom; Sabina C. Cosulich; Alison M. McCaig; Alison M. Michie
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
April Andrews; Kristy Warner; Christie Rodriguez-Ramirez; Alexander T. Pearson; Felipe Nör; Zhaocheng Zhang; Samuel Kerk; Aditi Kulkarni; Joseph I. Helman; J. Chad Brenner; Max S. Wicha; Shaomeng Wang; Jacques E. Nör
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Valentina Gambardella; Francisco Gimeno-Valiente; Noelia Tarazona; Carolina Martinez Ciarpaglini; Desamparados Roda; Tania Fleitas; Pablo Tolosa; Juan Miguel Cejalvo; Marisol Huerta; Susana Roselló; Josefa Castillo; Andrés Cervantes
The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
Daniel A.R. Heisey; Timothy L. Lochmann; Konstantinos V. Floros; Colin M. Coon; Krista M. Powell; Sheeba Jacob; Marissa L. Calbert; Maninderjit S. Ghotra; Giovanna T. Stein; Yuki Kato Maves; Steven C. Smith; Cyril H. Benes; Joel D. Leverson; Andrew J. Souers; Sosipatros A. Boikos; Anthony C. Faber
Author Choice
Anagrelide for Gastrointestinal Stromal Tumor
Olli-Pekka Pulkka; Yemarshet K. Gebreyohannes; Agnieszka Wozniak; John-Patrick Mpindi; Olli Tynninen; Katherine Icay; Alejandra Cervera; Salla Keskitalo; Astrid Murumägi; Evgeny Kulesskiy; Maria Laaksonen; Krister Wennerberg; Markku Varjosalo; Pirjo Laakkonen; Rainer Lehtonen; Sampsa Hautaniemi; Olli Kallioniemi; Patrick Schöffski; Harri Sihto; Heikki Joensuu
Letters to the Editor
DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies—Response
Andrew J. Bauer; Douglas R. Stewart; Junne Kamihara; Anne K. Harris; Joyce Turner; Rachana Shah; Kami Wolfe Schneider; Katherine Schneider; Ann Garrity Carr; Laura A. Harney; A. Lindsay Frazier; Daniel Orbach; Dominik T. Schneider; David Malkin; Louis P. Dehner; Yoav H. Messinger; D. Ashley Hill; Kris Ann P. Schultz
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds